These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26666932)

  • 21. Prevalence and contributing factors of nonsusceptibility to imipenem or meropenem in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    Park YJ; Yu JK; Park KG; Park YG; Lee S; Kim SY; Jeong SH
    Diagn Microbiol Infect Dis; 2011 Sep; 71(1):87-9. PubMed ID: 21397426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extended-spectrum beta-lactam resistance due to AmpC hyperproduction and CMY-2 coupled with the loss of OMPK35 in Malaysian strains of Escherichia coli and Klebsiella pneumoniae.
    Palasubramaniam S; Subramaniam G; Muniandy S; Parasakthi N
    Microb Drug Resist; 2007; 13(3):186-90. PubMed ID: 17949305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Collateral damage of flomoxef therapy: in vivo development of porin deficiency and acquisition of blaDHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 beta-lactamases.
    Lee CH; Chu C; Liu JW; Chen YS; Chiu CJ; Su LH
    J Antimicrob Chemother; 2007 Aug; 60(2):410-3. PubMed ID: 17576696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cloverleaf test (modified Hodge test) for detecting carbapenemase production in Klebsiella pneumoniae: be aware of false positive results.
    Carvalhaes CG; Picão RC; Nicoletti AG; Xavier DE; Gales AC
    J Antimicrob Chemother; 2010 Feb; 65(2):249-51. PubMed ID: 19996141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. OmpK35 and OmpK36 porin variants associated with specific sequence types of Klebsiella pneumoniae.
    Papagiannitsis CC; Giakkoupi P; Kotsakis SD; Tzelepi E; Tzouvelekis LS; Vatopoulos AC; Miriagou V
    J Chemother; 2013 Aug; 25(4):250-4. PubMed ID: 23906079
    [No Abstract]   [Full Text] [Related]  

  • 26. Crystal structure and functional characterization of OmpK36, the osmoporin of Klebsiella pneumoniae.
    Dutzler R; Rummel G; Albertí S; Hernández-Allés S; Phale P; Rosenbusch J; Benedí V; Schirmer T
    Structure; 1999 Apr; 7(4):425-34. PubMed ID: 10196126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction between complement subcomponent C1q and the Klebsiella pneumoniae porin OmpK36.
    Albertí S; Marqués G; Hernández-Allés S; Rubires X; Tomás JM; Vivanco F; Benedí VJ
    Infect Immun; 1996 Nov; 64(11):4719-25. PubMed ID: 8890231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced imipenem susceptibility in Klebsiella pneumoniae clinical isolates with plasmid-mediated CMY-2 and DHA-1 beta-lactamases co-mediated by porin loss.
    Lee K; Yong D; Choi YS; Yum JH; Kim JM; Woodford N; Livermore DM; Chong Y
    Int J Antimicrob Agents; 2007 Feb; 29(2):201-6. PubMed ID: 17204406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbapenem-nonsusceptible strains of Klebsiella pneumoniae producing SHV-5 and/or DHA-1 beta-lactamases in a Czech hospital.
    Chudácková E; Bergerová T; Fajfrlík K; Cervená D; Urbásková P; Empel J; Gniadkowski M; Hrabák J
    FEMS Microbiol Lett; 2010 Aug; 309(1):62-70. PubMed ID: 20528936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics of carbapenem-resistant Enterobacteriaceae isolates from Korea.
    Kim SY; Shin J; Shin SY; Ko KS
    Diagn Microbiol Infect Dis; 2013 Aug; 76(4):486-90. PubMed ID: 23688521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outer membrane protein profiles of clonally related Klebsiella pneumoniae isolates that differ in cefoxitin resistance.
    Skopková-Zarnayová M; Siebor E; Rovná D; Bujdáková H; Neuwirth C
    FEMS Microbiol Lett; 2005 Feb; 243(1):197-203. PubMed ID: 15668019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three Dimensional Checkerboard Synergy Analysis of Colistin, Meropenem, Tigecycline against Multidrug-Resistant Clinical Klebsiella pneumonia Isolates.
    Stein C; Makarewicz O; Bohnert JA; Pfeifer Y; Kesselmeier M; Hagel S; Pletz MW
    PLoS One; 2015; 10(6):e0126479. PubMed ID: 26067824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection and prevalence of active drug efflux mechanism in various multidrug-resistant Klebsiella pneumoniae strains from Turkey.
    Hasdemir UO; Chevalier J; Nordmann P; Pagès JM
    J Clin Microbiol; 2004 Jun; 42(6):2701-6. PubMed ID: 15184455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contribution of outer membrane protein K36 to antimicrobial resistance and virulence in Klebsiella pneumoniae.
    Chen JH; Siu LK; Fung CP; Lin JC; Yeh KM; Chen TL; Tsai YK; Chang FY
    J Antimicrob Chemother; 2010 May; 65(5):986-90. PubMed ID: 20211860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In Vitro Activity of Imipenem and Colistin against a Carbapenem-Resistant Klebsiella pneumoniae Isolate Coproducing SHV-31, CMY-2, and DHA-1.
    Tang HJ; Ku YH; Lee MF; Chuang YC; Yu WL
    Biomed Res Int; 2015; 2015():568079. PubMed ID: 26064923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The mechanism of high-level carbapenem resistance in Klebsiella pneumoniae: underlying Ompk36-deficient strains represent a threat of emerging high-level carbapenem-resistant K. pneumoniae with IMP-1 β-lactamase production in Japan.
    Sho T; Muratani T; Hamasuna R; Yakushiji H; Fujimoto N; Matsumoto T
    Microb Drug Resist; 2013 Aug; 19(4):274-81. PubMed ID: 23514607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A porin from Klebsiella pneumoniae: sequence homology, three-dimensional model, and complement binding.
    Albertí S; Rodríquez-Quiñones F; Schirmer T; Rummel G; Tomás JM; Rosenbusch JP; Benedí VJ
    Infect Immun; 1995 Mar; 63(3):903-10. PubMed ID: 7868262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emergence of carbapenem resistance due to porin loss in an extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae strain during meropenem therapy.
    Webster DP; Gaulton T; Woodford N; Pike R; Turton J; Perry C; Bowler IC
    Int J Antimicrob Agents; 2010 Dec; 36(6):575-6. PubMed ID: 20869852
    [No Abstract]   [Full Text] [Related]  

  • 39. High-level carbapenem-resistant OXA-48-producing Klebsiella pneumoniae with a novel OmpK36 variant and low-level, carbapenem-resistant, non-porin-deficient, OXA-181-producing Escherichia coli from Thailand.
    Lunha K; Chanawong A; Lulitanond A; Wilailuckana C; Charoensri N; Wonglakorn L; Saenjamla P; Chaimanee P; Angkititrakul S; Chetchotisakd P
    Diagn Microbiol Infect Dis; 2016 Jun; 85(2):221-6. PubMed ID: 27041106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of resistance during antimicrobial therapy caused by insertion sequence interruption of porin genes.
    Hernández-Allés S; Benedí VJ; Martínez-Martínez L; Pascual A; Aguilar A; Tomás JM; Albertí S
    Antimicrob Agents Chemother; 1999 Apr; 43(4):937-9. PubMed ID: 10103203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.